CMV-NLS-AcrIIA4 Citations (2)
Originally described in: Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.Bubeck F, Hoffmann MD, Harteveld Z, Aschenbrenner S, Bietz A, Waldhauer MC, Borner K, Fakhiri J, Schmelas C, Dietz L, Grimm D, Correia BE, Eils R, Niopek D Nat Methods. 2018 Oct 30. pii: 10.1038/s41592-018-0178-9. doi: 10.1038/s41592-018-0178-9. PubMed Journal
Articles Citing CMV-NLS-AcrIIA4
| Articles |
|---|
A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins.
Gama-Brambila RA, Chen J, Dabiri Y, Tascher G, Nemec V, Munch C, Song G, Knapp S, Cheng X.
JACS Au. 2021 May 12;1(6):777-785. doi: 10.1021/jacsau.1c00007. eCollection 2021 Jun 28.
PubMed
Associated Plasmids |
| In vitro genome editing activity of Cas9 in somatic cells after random and transposon-based genomic Cas9 integration. Sollner JH, Sake HJ, Frenzel A, Lechler R, Herrmann D, Fuchs W, Petersen B. PLoS One. 2022 Dec 30;17(12):e0279123. doi: 10.1371/journal.pone.0279123. eCollection 2022. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.